BridgeBio Oncology (BBOT)

• Market cap: $789M
• 1 day: -2.08%
• 5 days: -4.36%
• 1 month: -16.92%
• 3 months: -10.84%
• 6 months: 0.3%
• Year to date: -19.69%
• 1 year: -9.37%
• 5 years: -3.14%
• 10 years: -3.14%
• Sector: Healthcare
• Industry: Biotechnology

About: BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.

Employees: 81